Campus Capital
Accelerate Places, 101 Princess Street, Manchester, M1 6DD, United Kingdom
Overview
Campus Capital is a VC that will work in partnership with a number of the UK’s leading universities to deliver on-campus venture capital funds. Each Campus Capital fund is to be part-run by active students who will act under the guidance and supervision of the Campus Capital board and an FCA authorised fund manager.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 1
- Active investors
- 0
Investment portfolio
- Detechgene
Participated · Seed · Aug 2025
Detechgene is a spin-off from the Nephrolab of the University Hospital Cologne Medicine II, founded in 2022. The company has developed a cartridge system for rapid nucleic acid detection that meets medical standards and enables quick, precise pathogen detection without additional equipment. Its flagship solution, branded ‘PCR to Go’, is a mobile molecular biology diagnostics system intended for on-site use and able to detect a wide range of pathogens in a very short time. Detechgene positions the product to combine PCR-level precision with the ease of a rapid antigen test. The firm says this technology opens market opportunities for customised testing solutions and aims to make laboratory diagnostics fast, mobile and accessible to everyone. Detechgene completed a financing round to advance development and deployment of its mobile diagnostics offering.
Team
No current team members are available.